Carnitine: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
== Application in [[HRFR]] == | == Application in [[HRFR]] == | ||
::::* '''L-carnitine:''' Sigma Aldrich; C0158; FW=161.2 | ::::* '''L-carnitine:''' Sigma Aldrich; C0158; FW=161.2 | ||
== Feeding carnitine == | |||
::::* http://wiki.oroboros.at/index.php/Liu_2002_Proc_Natl_Acad_Sci_U_S_A | |||
::::* http://wiki.oroboros.at/index.php/La_Guardia_2013_Front_Physiol | |||
::::* http://wiki.oroboros.at/index.php/Morand_2014_Eur_J_Nutr | |||
::::* http://wiki.oroboros.at/index.php/Cahova_2014_Appl_Physiol_Nutr_Metab | |||
::::* http://wiki.oroboros.at/index.php/Wessels_2015_Am_J_Physiol |
Revision as of 17:30, 12 October 2018
Description
Carnitine is an important factor for the transport of long-chain fatty acids bound to carnitine (carnitine acyltransferase) into the mitochondrial matrix for subsequent β-oxidation. There are two enantiomers: D- and L-carnitine. Only the L-isomer is physiologically active.
Abbreviation: Car
MitoPedia topics: Substrate and metabolite
Application in HRFR
- L-carnitine: Sigma Aldrich; C0158; FW=161.2
Feeding carnitine
- http://wiki.oroboros.at/index.php/Liu_2002_Proc_Natl_Acad_Sci_U_S_A
- http://wiki.oroboros.at/index.php/La_Guardia_2013_Front_Physiol
- http://wiki.oroboros.at/index.php/Morand_2014_Eur_J_Nutr
- http://wiki.oroboros.at/index.php/Cahova_2014_Appl_Physiol_Nutr_Metab
- http://wiki.oroboros.at/index.php/Wessels_2015_Am_J_Physiol